Myocardial regeneration by transplantation of modified endothelial progenitor cells expressing SDF-1 in a rat model

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 10, 2012, Pages 2311-2320

  Schuh, Alexander ^a   Kroh, Andreas ^a   Konschalla, Simone ^a   Liehn, Elisa A ^a   Sobota, Radoslav M ^b   Biessen, Erik Al ^c   Bot, Ilze ^d   Tolga Taha, Sönmez ^a   Schober, Andreas ^a   Marx, Nikolaus ^a   Weber, Christian ^a,e,f   Sasse, Alexander ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cell transplantation; Chemokines; Endothelial progenitor cells; Heart regeneration; Myocardial infarction

Indexed keywords

COLLAGEN; CXCL12 PROTEIN, RAT; STROMAL CELL DERIVED FACTOR 1;

ANIMAL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEK293; CYTOLOGY; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE; HUMAN; INFLAMMATION; LENTIVIRINAE; METABOLISM; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); NICK END LABELING; PATHOLOGY; RAT; REGENERATION; SPLEEN; SPRAGUE DAWLEY RAT; STEM CELL; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; APOPTOSIS; CARDIAC CATHETERIZATION; CELL PROLIFERATION; CHEMOKINE CXCL12; COLLAGEN; ECHOCARDIOGRAPHY; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; IN SITU NICK-END LABELING; INFLAMMATION; LENTIVIRUS; MODELS, ANIMAL; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; SPLEEN; STEM CELL TRANSPLANTATION; STEM CELLS;

ANIMALIA; RATTUS; RODENTIA;

EID: 84866757683     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01539.x     Document Type: Article

References (36)

1. Tomita S, Li RK, Weisel RDet al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 1999; 100: II247-56.
2. Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol. 2001; 37: 1726-32.
3. Skobel E, Schuh A, Schwarz ER, et al. Transplantation of foetal cardiomyocytes into infarcted rat hearts results in long-term functional improvement. Tissue Eng. 2004; 10: 849-64.
4. Merx MW, Zernecke A, Liehn EA, et al. Transplantation of human umbilical vein endothelial cells improves left ventricular function in a rat model of myocardial infarction. Basic Res Cardiol. 2005; 100: 208-16.
5. Schuh A, Liehn EA, Sasse A, et al. Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model. Basic Res Cardiol. 2008; 103: 69-77.
6. Schuh A, Liehn EA, Sasse A, et al. Improved left ventricular function after transplantation of microspheres and fibroblasts in a rat model of myocardial infarction. Basic Res Cardiol. 2009; 104: 403-11.
7. Schuh A, Breuer S, Al Dashti R, et al. Administration of vascular endothelial growth factor adjunctive to foetal cardiomyocyte transplantation and improvement of cardiac function in the rat model. J Cardiovasc Pharmacol Ther. 2005; 10: 55-66.
8. Dubois C, Liu X, Claus P, et al. Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction. J Am Coll Cardiol. 2010; 55: 2232-43.
9. Nakamura Y, Yasuda T, Weisel RD, et al. Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function. Am J Physiol Heart Circ Physiol. 2006; 291: H939-47.
10. Yang JF, Zhou WW, Tang T, et al. Effects of myocardial transplantation of mesenchymal stem cells transfected with vascular endothelial factor gene on improvement of heart function and angiogenesis after myocardial infarction: experiment with rats. Zhonghua Yi Xue Za Zhi. 2006; 86: 1027-34.
11. Elmadbouh I, Haider HKh, Jiang S, et al. Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol. 2007; 42: 792-803.
12. Seppen J, Rijnberg M, Cooreman MP et al. Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes. J Hepatol. 2002; 36: 459-65.
13. Zufferey R, Dull T, Mandel RJ, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol. 1998; 72: 9873-80.
14. Bot I, Guo J, Van Eck M, et al. Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to persistent knockdown of CCR2 function in vivo. Blood. 2005; 106: 1147-53.
15. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009; 324: 98-110.
16. Chavakis E, Koyanagi M, Dimmeler S. Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back. Circulation. 2010; 121: 325-35.
17. Lipinski MJ, Biondi-Zoccai GG, Abbate A, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol. 2007; 50: 1761-7.
18. Tongers J, Losordo DW, Landmesser U. Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J. 2011; 32: 1197-206.
19. Ding Z, Fach C, Sasse A, et al. A minimally invasive approach for efficient gene delivery to rodent hearts. Gene Ther. 2004; 11: 260-5.
20. Tang J, Wang J, Song H, et al. Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actions. Mol Biol Rep. 2010; 37: 1957-69.
21. Rong SL, Lu YX, Liao YH, et al. Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats. Chin Med J. 2008; 121: 347-54.
22. Yu G, Dai H, Chen J, et al. Gene delivery of indoleamine 2, 3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses. J Gene Med. 2008; 10: 754-61.
23. Gao F, He T, Wang H, et al. A promising strategy for the treatment of ischemic heart disease: mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Can J Cardiol. 2007; 23: 891-8.
24. Jo J, Nagaya N, Miyahara Y, et al. Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran. Tissue Eng. 2007; 13: 313-22.
25. Mazighi M, Tchétché D, Gouëffic Y, et al. Percutaneous transplantation of genetically-modified autologous fibroblasts in the rabbit femoral artery: a novel approach for cardiovascular gene therapy. J Vasc Surg. 2006; 44: 1067-75.
26. Spiegelstein D, Kim C, Zhang Y, et al. Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival. Am J Physiol Heart Circ Physiol. 2007; 293: H3311-6.
27. Bao C, Guo J, Lin G, et al. TNFR gene-modified mesenchymal stem cells attenuate inflammation and cardiac dysfunction following MI. Scand Cardiovasc J. 2008; 42: 56-62.
28. Dai Y, Ashraf M, Zuo S, et al. Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair. J Mol Cell Cardiol. 2008; 44: 607-17.
29. Liu XH, Bai CG, Xu ZY, et al. Therapeutic potential of angiogenin modified mesenchymal stem cells: angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction. Microvasc Res. 2008; 76: 23-30.
30. Sun L, Cui M, Wang Z, et al. Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction. Biochem Biophys Res Commun. 2007; 357: 779-84.
31. Zhou YL, Zhang HF, Li XL, et al. Increased stromal-cell-derived factor 1 enhances the homing of bone marrow derived mesenchymal stem cells in dilated cardiomyopathy in rats. Chin Med J. 2010; 123: 3282-7.
32. Wen Z, Zheng S, Zhou C, et al. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med. 2011; 15: 1032-43.
33. Klopsch C, Furlani D, Gäbel R, et al. Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J Cell Mol Med. 2009; 13: 664-79.
34. Frangogiannis NG, Entman ML. Chemokines in myocardial ischemia. Trends Cardiovasc Med. 2005; 15: 163-9.
35. Liehn EA, Tuchscheerer N, Kanzler I, et al. Double-edged role of the CXCL12-CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol. 2011; 58: 2415-23.
36. Lee BC, Lee TH, Avraham S, et al. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res. 2004; 2: 327-38.